Pharmacokinetic boosters
- Intentionally inhibit drug metabolism/transport
- Ritonavir/cobicistat are prototypes
- Raise exposure of a companion antiviral
- Creates major interaction burden with other drugs
- Booster has little/no target efficacy in some regimens
- Always review CYP3A/P-gp victim drugs
Class at a glance
- Intentionally inhibit drug metabolism/transport
Practical pearls
- Ritonavir/cobicistat are prototypes
Pharmacology
- Always review CYP3A/P-gp victim drugs
Members / distinctions
- Raise exposure of a companion antiviral
- Creates major interaction burden with other drugs
- Booster has little/no target efficacy in some regimens
Self-check
- What is the main pharmacologic action of Pharmacokinetic boosters?
Intentionally inhibit drug metabolism/transport.
- What clinically distinguishes Booster within Pharmacokinetic boosters?
little/no target efficacy in some.
Drugs in this class (2)
All drug classes · Open the interactive console ↗
